Condition: Aortic Stenosis · Sponsor: Medtronic Cardiovascular
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
This description comes directly from the study's public registry record.
RESTORE Study Clinical Team · 763 514 4000 · RS.RESTORESTUDY@medtronic.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Abrazo Arizona Heart Hospital | Phoenix, Arizona, United States | Recruiting |
| Tucson Medical Center | Tucson, Arizona, United States | Recruiting |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | Recruiting |
| Sutter Heatlh | Sacramento, California, United States | Recruiting |
| Kaiser Permanente Northern California | Sacramento, California, United States | Recruiting |
| Stanford Hospital & Clinics | Stanford, California, United States | Recruiting |
| Los Robles Regional Medical Center | Thousand Oaks, California, United States | Recruiting |
| Medical Center of the Rockies | Loveland, Colorado, United States | Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Recruiting |
| Yale New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| MedStar Washington Medical Center | Washington D.C., District of Columbia, United States | Recruiting |
+ 59 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.